Reuters: Regulatory News: Claris Lifesciences' Levofloxacin injection gets US FDA nod

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Claris Lifesciences' Levofloxacin injection gets US FDA nod Jun 7th 2013, 03:50 June 7 | Thu Jun 6, 2013 11:50pm EDT June 7 (Reuters) - Indian drugmaker Claris Lifesciences Ltd said late on Thursday that U.S. health regulators approved its antibiotic Levofloxacin injection. The U.S. Food and Drug Administration approved Levofloxacin, which can be used to treat adults suffering from pneumonia, acute bacterial sinusitis or complicated urinary tract infections, the company said in a statement.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions